Display options
Share it on

Leuk Lymphoma. 2022 Jan 12;1-5. doi: 10.1080/10428194.2021.2023741. Epub 2022 Jan 12.

CD38 is a potential treatment target in lymphoma patients concurrently infected with human immunodeficiency virus.

Leukemia & lymphoma

Trine Engelbrecht Hybel, Maja Ølholm Vase, Kristina Lystlund Lauridsen, Marie Beck Enemark, Michael Boe Møller, Court Pedersen, Gitte Pedersen, Stephen Hamilton-Dutoit, Niels Obel, Carsten Schade Larsen, Francesco d'Amore, Maja Ludvigsen

Affiliations

  1. Department of Hematology, Aarhus University Hospital, Aarhus, Denmark.
  2. Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
  3. Department of Pathology, Aarhus University Hospital, Aarhus, Denmark.
  4. Department of Pathology, Odense University Hospital, Odense, Denmark.
  5. Department of Infectious Diseases, Odense University Hospital, Odense, Denmark.
  6. Department of Infectious Diseases, Aalborg University Hospital, Aalborg, Denmark.
  7. Department of Infectious Diseases, Copenhagen University Hospital, Copenhagen, Denmark.
  8. Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark.

PMID: 35019824 DOI: 10.1080/10428194.2021.2023741

[No abstract available.]

Publication Types